TNSN98120A1 - 5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine. - Google Patents

5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine.

Info

Publication number
TNSN98120A1
TNSN98120A1 TNTNSN98120A TNSN98120A TNSN98120A1 TN SN98120 A1 TNSN98120 A1 TN SN98120A1 TN TNSN98120 A TNTNSN98120 A TN TNSN98120A TN SN98120 A TNSN98120 A TN SN98120A TN SN98120 A1 TNSN98120 A1 TN SN98120A1
Authority
TN
Tunisia
Prior art keywords
ethyle
tetrazole
tetrahydropuridine
methyle
phrmaceutical
Prior art date
Application number
TNTNSN98120A
Other languages
English (en)
French (fr)
Inventor
Bech Sommer Michael
Nielsen Ole
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TNSN98120A1 publication Critical patent/TNSN98120A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TNTNSN98120A 1997-07-01 1998-06-30 5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine. TNSN98120A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
TNSN98120A1 true TNSN98120A1 (fr) 2005-03-15

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98120A TNSN98120A1 (fr) 1997-07-01 1998-06-30 5 - (2-ethyle - 2h-tetrazole - 5yl) - 1 - methyle - 1,2,3,6 - tetrahydropuridine.

Country Status (25)

Country Link
EP (1) EP0994869A1 (ar)
JP (1) JP2002507215A (ar)
KR (1) KR20010014297A (ar)
CN (1) CN1261361A (ar)
AR (1) AR013096A1 (ar)
AU (1) AU735751B2 (ar)
BG (1) BG103933A (ar)
BR (1) BR9810331A (ar)
CA (1) CA2293324A1 (ar)
CO (1) CO4940483A1 (ar)
EA (1) EA200000081A1 (ar)
HU (1) HUP0002876A2 (ar)
IL (1) IL133093A0 (ar)
IS (1) IS5278A (ar)
JO (1) JO2031B1 (ar)
MA (1) MA25138A1 (ar)
NO (1) NO996580D0 (ar)
PE (1) PE116099A1 (ar)
PL (1) PL337184A1 (ar)
SK (1) SK187399A3 (ar)
TN (1) TNSN98120A1 (ar)
TR (1) TR199903283T2 (ar)
UY (2) UY25069A1 (ar)
WO (1) WO1999001448A1 (ar)
ZA (1) ZA985498B (ar)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
HUP9901051A2 (hu) * 1995-11-06 2000-03-28 H. Lundbeck A/S 5-(2-Etil-2H-tetrazol-5-il)-1,2,3,6-tetrahidro-1-metil-piridin alkalmazása traumás agykárosodások kezelésére alkalmas gyógyászati készítmények előállítására

Also Published As

Publication number Publication date
JP2002507215A (ja) 2002-03-05
IS5278A (is) 1999-11-30
PE116099A1 (es) 1999-11-23
UY25069A1 (es) 1998-12-21
SK187399A3 (en) 2000-06-12
TR199903283T2 (xx) 2000-06-21
CO4940483A1 (es) 2000-07-24
AU8102098A (en) 1999-01-25
EP0994869A1 (en) 2000-04-26
AR013096A1 (es) 2000-12-13
NO996580L (no) 1999-12-30
ZA985498B (en) 1999-01-20
NO996580D0 (no) 1999-12-30
IL133093A0 (en) 2001-03-19
CN1261361A (zh) 2000-07-26
EA200000081A1 (ru) 2000-08-28
BR9810331A (pt) 2000-09-05
JO2031B1 (ar) 1999-05-15
WO1999001448A1 (en) 1999-01-14
KR20010014297A (ko) 2001-02-26
AU735751B2 (en) 2001-07-12
MA25138A1 (fr) 2001-04-02
UY25177A1 (es) 2000-12-29
PL337184A1 (en) 2000-08-14
CA2293324A1 (en) 1999-01-14
BG103933A (en) 2000-07-31
HUP0002876A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
TNSN98154A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN01126A1 (fr) Imidazoles substitues nouveaux, procede pour leur preparation et compositions les contenant
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
BG106771A (en) Heterocyclic substituted pyrazolones
TNSN98104A1 (fr) Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA32655B1 (ar) مركبات تعدل بشكل انتقائي مستقبل cb2
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0786995A4 (ar)
MA28093A1 (fr) Forme polymorphe de 3-phenylsulfonyl-8-piperazine-1-yl-quinoleine
TNSN98227A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant.
TNSN99001A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
TNSN01046A1 (fr) Ethers de diphenyle utiles en therapeutique
MA26739A1 (fr) Sel mutuel d'amlodipine et d'atorvastatine, procede pour sa preparation et compositions pharmaceutiques les contenant
TNSN96174A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant.
MA26741A1 (fr) Suspensions de ziprasidone nouvelles et procede pour leur preparation.
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97039A1 (fr) Derives d'oxadiazole et de thiadiazole antagonistes des recepteurs muscariniques.
TNSN99056A1 (fr) Composes azabicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00106A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation
MA26541A1 (fr) Nouvelles imidazolines, procede pour les preparer, compositions pharmaceutiques les contenant et leur utilisation dans le traitement de maladies soulagees par un traitement avec un antagoniste des recepteurs des prostaglandines